Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 3
1995 1
1996 2
1998 3
1999 3
2000 2
2001 2
2002 4
2003 1
2004 5
2005 2
2006 4
2007 1
2009 2
2010 1
2011 2
2012 2
2013 2
2014 1
2015 5
2016 1
2017 1
2019 2
2021 1
2022 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

54 results

Results by year

Filters applied: . Clear all
Page 1
Nivolumab and ipilimumab in recurrent or refractory cancer of unknown primary: a phase II trial.
Pouyiourou M, Kraft BN, Wohlfromm T, Stahl M, Kubuschok B, Löffler H, Hacker UT, Hübner G, Weiss L, Bitzer M, Ernst T, Schütt P, Hielscher T, Delorme S, Kirchner M, Kazdal D, Ball M, Kluck K, Stenzinger A, Bochtler T, Krämer A. Pouyiourou M, et al. Among authors: kubuschok b. Nat Commun. 2023 Oct 24;14(1):6761. doi: 10.1038/s41467-023-42400-5. Nat Commun. 2023. PMID: 37875494 Free PMC article. Clinical Trial.
Management of diffuse large B-cell lymphoma (DLBCL).
Kubuschok B, Held G, Pfreundschuh M. Kubuschok B, et al. Cancer Treat Res. 2015;165:271-88. doi: 10.1007/978-3-319-13150-4_11. Cancer Treat Res. 2015. PMID: 25655614 Review.
Identification of the atypically modified autoantigen Ars2 as the target of B-cell receptors from activated B-cell-type diffuse large B-cell lymphoma.
Thurner L, Hartmann S, Bewarder M, Fadle N, Regitz E, Schormann C, Quiroga N, Kemele M, Klapper W, Rosenwald A, Trümper L, Bohle RM, Nimmesgern A, Körbel C, Lascke MW, Menger MD, Barth S, Kubuschok B, Mottok A, Kaddu-Mulindwa D, Hansmann ML, Pöschel V, Held G, Murawski N, Stilgenbauer S, Neumann F, Preuss KD, Pfreundschuh M. Thurner L, et al. Among authors: kubuschok b. Haematologica. 2021 Aug 1;106(8):2224-2232. doi: 10.3324/haematol.2019.241653. Haematologica. 2021. PMID: 32675228 Free PMC article.
B-cell receptors of EBV-negative Burkitt lymphoma bind modified isoforms of autoantigens.
Bock T, Bewarder M, Cetin O, Fadle N, Regitz E, Schwarz EC, Held J, Roth S, Lohse S, Pfuhl T, Wagener R, Smola S, Becker SL, Bohle RM, Trümper L, Siebert R, Hansmann ML, Pfreundschuh M, Drexler HG, Hoth M, Kubuschok B, Roemer K, Preuss KD, Hartmann S, Thurner L. Bock T, et al. Among authors: kubuschok b. EJHaem. 2022 Jun 16;3(3):739-747. doi: 10.1002/jha2.475. eCollection 2022 Aug. EJHaem. 2022. PMID: 36051037 Free PMC article.
[Periodic fever and pancytopenia in a 35-year-old patient].
Schmutz M, Schaller T, Kubuschok B, Fleischmann C, Hirschbühl K, Dintner S, Häckel T, Märkl B, Trepel M, Claus R. Schmutz M, et al. Among authors: kubuschok b. Internist (Berl). 2019 Dec;60(12):1305-1310. doi: 10.1007/s00108-019-00679-x. Internist (Berl). 2019. PMID: 31549186 German.
KIT D816 mutated/CBF-negative acute myeloid leukemia: a poor-risk subtype associated with systemic mastocytosis.
Jawhar M, Döhner K, Kreil S, Schwaab J, Shoumariyeh K, Meggendorfer M, Span LLF, Fuhrmann S, Naumann N, Horny HP, Sotlar K, Kubuschok B, von Bubnoff N, Spiekermann K, Heuser M, Metzgeroth G, Fabarius A, Klein S, Hofmann WK, Kluin-Nelemans HC, Haferlach T, Döhner H, Cross NCP, Sperr WR, Valent P, Reiter A. Jawhar M, et al. Among authors: kubuschok b. Leukemia. 2019 May;33(5):1124-1134. doi: 10.1038/s41375-018-0346-z. Epub 2019 Jan 11. Leukemia. 2019. PMID: 30635631 Free PMC article.
The molecular basis for development of proinflammatory autoantibodies to progranulin.
Thurner L, Fadle N, Regitz E, Kemele M, Klemm P, Zaks M, Stöger E, Bette B, Carbon G, Zimmer V, Assmann G, Murawski N, Kubuschok B, Held G, Preuss KD, Pfreundschuh M. Thurner L, et al. Among authors: kubuschok b. J Autoimmun. 2015 Jul;61:17-28. doi: 10.1016/j.jaut.2015.05.002. Epub 2015 May 23. J Autoimmun. 2015. PMID: 26005049
Clinical approaches to vaccination in oncology.
Renner C, Kubuschok B, Trümper L, Pfreundschuh M. Renner C, et al. Among authors: kubuschok b. Ann Hematol. 2001 May;80(5):255-66. doi: 10.1007/s002770100324. Ann Hematol. 2001. PMID: 11446727 Review.
54 results